Top 50 Medical Startup Investors in Japan (October 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Mitsubishi UFJ Capital
VC Fund
|
29 | Japan, United States, Israel | Series A, Venture - Series Unknown, Seed | Software, Information Technology, Manufacturing | $470k–$21M |
|
ANRI
VC Fund
|
22 | Japan, United States, Indonesia | Seed, Series A, Venture - Series Unknown | Software, Health Care, Information Technology | $268k–$41M |
|
JAFCO
VC Fund
|
18 | Japan, United States, India | Series A, Series B, Venture - Series Unknown | Information Technology, Software, Artificial Intelligence | $1.3M–$41M |
|
Fast Track Initiative, Inc.
VC Fund
|
17 | Japan, United States, United Kingdom | Series A, Series B, Seed | Health Care, Biotechnology, Medical | $345k–$117M |
|
SMBC Venture Capital
VC Fund
|
14 | Japan, United States, Singapore | Venture - Series Unknown, Series A, Series B | Information Technology, Software, Health Care | $800k–$34M |
|
UTEC - The University of Tokyo Edge Capital Partners
VC Fund
|
13 | Japan, United States, India | Series A, Seed, Venture - Series Unknown | Health Care, Biotechnology, Medical | $624k–$18M |
|
DNX Ventures
VC Fund
|
12 | Japan, United States, Canada | Seed, Series A, Series B | Software, Information Technology, Artificial Intelligence | $482k–$38M |
|
Nissay Capital
VC Fund
|
12 | Japan, United States, Ethiopia | Venture - Series Unknown, Seed, Series A | Health Care, Software, Medical | $455k–$12M |
|
UntroD Capital
VC Fund
|
11 | Japan, Singapore, Austria | Seed, Venture - Series Unknown, Series A | Manufacturing, Biotechnology, Health Care | $316k–$15M |
|
Keio Innovation Initiative
VC Fund
|
11 | Japan, United Kingdom | Series A, Seed, Venture - Series Unknown | Health Care, Medical, Biotechnology | $826k–$41M |
|
Global Brain Corporation
VC Fund
|
10 | Japan, United States, United Kingdom | Series A, Series B, Venture - Series Unknown | Software, Artificial Intelligence, Information Technology | $602k–$48M |
|
Nippon Venture Capital
VC Fund
|
8 | Japan, United States, Indonesia | Venture - Series Unknown, Series A, Series B | Health Care, Software, Medical | $457k–$45M |
|
Japan Science and Technology Agency
VC Fund
|
7 | Japan | Series A, Seed, Venture - Series Unknown | Biotechnology, Medical, Manufacturing | $975k–$15M |
|
Incubate Fund
VC Fund
|
7 | Japan, United States, India | Seed, Series A, Venture - Series Unknown | Software, Information Technology, Artificial Intelligence | $288k–$20M |
|
Coral Capital
VC Fund
|
7 | Japan, United States, Denmark | Seed, Series A, Series B | Software, Information Technology, SaaS | $468k–$184M |
|
Antler
VC Fund
|
7 | United States, Singapore, Australia | Pre-Seed, Seed, Series A | Software, Artificial Intelligence, Information Technology | $100k–$29M |
|
Mizuho Capital
VC Fund
|
7 | Japan, United States, Singapore | Series A, Venture - Series Unknown, Series B | Information Technology, Software, Artificial Intelligence | $661k–$47M |
|
Miyako Capital
VC Fund
|
7 | Japan, United States, United Kingdom | Series A, Seed, Series B | Medical, Biotechnology, Information Technology | $395k–$150M |
|
SBI Investment
VC Fund
|
7 | Japan, United States, South Korea | Series B, Series A, Venture - Series Unknown | Software, Information Technology, Financial Services | $1.3M–$62M |
|
Tsukuba Institute of Research
VC Fund
|
6 | Japan | Series A, Seed | Medical, Manufacturing, Health Care | $953k–$7.1M |
|
Osaka University Venture Capital
VC Fund
|
6 | Japan | Seed, Venture - Series Unknown, Series A | Biotechnology, Health Care, Medical | $480k–$19M |
|
Japan Finance Corporation
VC Fund
|
6 | Japan, Kenya, Hong Kong | Debt Financing, Seed, Venture - Series Unknown | Software, Information Technology, Artificial Intelligence | $212k–$13M |
|
MITSUI SUMITOMO INSURANCE Venture Capital (MSIVC)
VC Fund
|
6 | Japan, United States, India | Venture - Series Unknown, Seed, Series A | Software, Information Technology, Manufacturing | $482k–$16M |
|
REVIC
VC Fund
|
6 | Japan | Venture - Series Unknown, Seed, Series C | Manufacturing, Health Care, Medical | $15k–$27M |
|
DBJ Capital
VC Fund
|
6 | Japan, United States, Australia | Series A, Venture - Series Unknown, Series B | Software, Health Care, Biotechnology | $887k–$34M |
|
Mobile Internet Capital
VC Fund
|
6 | Japan, United States, China | Series A, Venture - Series Unknown | Software, Information Technology, Mobile | $547k–$50M |
|
ASICS Ventures Corporation
VC Fund
|
5 | Japan, India, Canada | Seed, Venture - Series Unknown, Series A | Health Care, Medical, Artificial Intelligence | $918k–$15M |
|
IT-Farm
VC Fund
|
5 | United States, Japan, Germany | Seed, Series A, Series B | Software, Health Care, Medical | $1M–$36M |
|
UTokyo Innovation Platform
VC Fund
|
5 | Japan, United States, United Kingdom | Series A, Series B | Biotechnology, Medical, Manufacturing | |
|
Capital Medica Ventures
VC Fund
|
4 | Japan | Seed, Series A, Venture - Series Unknown | Health Care, Medical, Software | $91k–$51M |
|
ITOCHU Technology Ventures
VC Fund
|
4 | Japan, United States, Belgium | Series A, Series B, Venture - Series Unknown | Software, Information Technology, E-Commerce | $1.3M–$38M |
|
Tohoku University Venture Partners
VC Fund
|
4 | Japan, China | Venture - Series Unknown, Seed, Series A | Manufacturing, Medical, Biotechnology | $271k–$8.8M |
|
QB Capital
VC Fund
|
4 | Japan, Singapore, United States | Seed, Venture - Series Unknown, Series A | Manufacturing, Medical, Biotechnology | $585k–$14M |
|
Real Tech Japan
VC Fund
|
4 | Japan, Singapore, Austria | Venture - Series Unknown, Seed, Series A | Manufacturing, Biotechnology, Robotics | $316k–$21M |
|
FFG Venture Business Partners
VC Fund
|
4 | Japan, Indonesia, United States | Series A, Venture - Series Unknown, Seed | Software, Artificial Intelligence, Health Care | $547k–$50M |
|
Angel Bridge
VC Fund
|
4 | Japan | Series A, Seed, Series B | Information Technology, Software, Consulting | $648k–$47M |
|
Senshu Ikeda Capital
VC Fund
|
4 | Japan | Venture - Series Unknown, Series A, Seed | Software, Manufacturing, Internet | $395k–$17M |
|
MedVenture Partners
VC Fund
|
4 | Japan, United States | Series B, Series A, Venture - Series Unknown | Medical Device, Health Care, Manufacturing | $931k–$11M |
|
DOGAN beta
VC Fund
|
4 | Japan, United States | Seed, Venture - Series Unknown, Series A | Information Technology, Apps, Software | $233k–$21M |
|
Kyogin Lease & Capital
VC Fund
|
4 | Japan | Series A, Venture - Series Unknown, Seed | Manufacturing, Medical, Information Technology | $90k–$16M |
|
Fujifilm
VC Fund
|
4 | Japan, United States, China | Series A, Venture - Series Unknown, Corporate Round | Biotechnology, Health Care, Medical | $1.3M–$1.7B |
|
MTG Ventures
VC Fund
|
3 | Japan | Seed, Series A | Health Care, Manufacturing, Marketing | $531k–$142M |
|
KSP
VC Fund
|
3 | Japan | Series A, Series B | Biotechnology, Health Care, Medical | |
|
Miraidoa
VC Fund
|
3 | Japan, United States, Myanmar | Seed, Venture - Series Unknown | Manufacturing, Health Care, Information Technology | $186k–$16M |
|
Genesia Ventures
VC Fund
|
3 | Japan, Vietnam, Indonesia | Seed, Series A, Venture - Series Unknown | Information Technology, Software, Artificial Intelligence | $404k–$11M |
|
Honda Motor
VC Fund
|
3 | United States, Japan, Germany | Corporate Round, Series A, Series C | Manufacturing, Renewable Energy, Energy | $3.3M–$2B |
|
Daiwa Corporate Investment
VC Fund
|
3 | Japan, United States, France | Venture - Series Unknown, Series A, Seed | Software, Manufacturing, Health Care | $310k–$9.2M |
|
Higin Capital
VC Fund
|
3 | Japan | Series A, Series B, Venture - Series Unknown | Medical, Biotechnology, Software | $279k–$17M |
|
Sumitomo Mitsui Banking Corporation
VC Fund
|
3 | Japan, United States, India | Debt Financing, Post-IPO Debt, Venture - Series Unknown | Energy, Financial Services, Renewable Energy | $1M–$3B |
|
D4V
VC Fund
|
3 | Japan, United States, Singapore | Seed, Series A, Venture - Series Unknown | Software, Financial Services, E-Commerce | $292k–$14M |
| Access all 971 investors in Japan Medical startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Mitsubishi UFJ Capital is a venture capital firm focusing on life science, ICT, and high technology investments.
Show more...Investment focus
- Industry: Software, Information Technology, Manufacturing
- Stage:Series A, Venture - Series Unknown, Seed
- Geography: Japan, United States, Israel
Investor stats
- Total investments: 689
- Round size: Seed $470k–$16M; Series A $1.2M–$21M; Venture - Series Unknown $525k–$11M
- Lead/follow: 10% lead, 90% follow
- Last fund: May invest from a new fund soon — raised $94M in 2020
Portfolio highlights
- Smart Craft —
- Luxna Biotech — Luxana Biotech is a biotechnology firm dedicated to promoting the practical use of safe and effective nucleic acid therapies. Utilizing nucleic acid chemistry technology, the company strives to provide nucleic acid medicines to patients suffering from diseases that currently lack effective treatments.
- Link Therapeutics — Link Therapeutics specializes in developing therapeutic methods for targeting autoantibodies and identifying pathogenic autoantibodies.
ANRI is a Japanese venture capital firm that mainly invests in seed and early-stage startups.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Japan, United States, Indonesia
Investor stats
- Total investments: 315
- Round size: Seed $268k–$9.9M; Series A $967k–$41M; Venture - Series Unknown $616k–$9.1M
- Lead/follow: 24% lead, 76% follow
- Last fund: Likely still investing — raised $102M in 2022
Portfolio highlights
- Any Style — Any Style develops a messaging app from voice actors that regularly sends messages via subscription. It also engages in the planning and production of audio content and the VTuber production business.
- Arrowsmith — Arrowsmith is committed to unlocking the full potential of bacteriophages to revolutionize the treatment of bacterial infectious diseases. Through transformative science, Arrowsmith strive to create a world free from the pain and fear caused by antimicrobial resistance.
- Typewriter Therapeutics — Typewriter Therapeutics, Inc. develops mRNA-based gene therapies using a gene writing, or gene writing, platform for precise insertion of therapeutic genes into the genome. The company builds on transposon-based technologies originating from research by Professor Emeritus Haruhiko Fujiwara at the University of Tokyo. Its programs focus on all‑RNA,nonviral gene writing systems that repurpose natural genetic elements to address severe genetic disorders with limited treatment options. Typewriter Therapeutics conducts research and development across its U.S. and Japan operations and collaborates with investors and partners to advance genetic medicine candidates toward the clinic.
Since its founding in 1973, JAFCO has always worked with leading-edge entrepreneurs. The total capital commitments of its investment funds in Japan and overseas have exceeded 1 trillion yen and the number of portfolio IPOs to date has reached over 1,000. In addition to venture investment, JAFCO also carries out buyout investment and commit to the creations of innovative technologies and services worldwide. As entrepreneurs’ closest partner in bringing their visions to life, JAFCO provides support in areas of HR, marketing/ sales, and back-office operations, in addition to providing financing.
Show more...Investment focus
- Industry: Information Technology, Software, Artificial Intelligence
- Stage:Series A, Series B, Venture - Series Unknown
- Geography: Japan, United States, India
Investor stats
- Total investments: 371
- Round size: Series A $2.1M–$41M; Series B $4.2M–$36M; Venture - Series Unknown $1.3M–$13M
- Lead/follow: 35% lead, 65% follow
- Last fund: May invest from a new fund soon — raised $567M in 2019
Portfolio highlights
- CaTe — CaTe is based in Tokyo. CaTe develops and manufactures a Digital Therapeutic (DTx) for remote cardiac rehabilitation. Their invention allows heart disease patients to safely and successfully complete cardiac rehabilitation utilizing standing exercise in a confined space, such as at home, without the use of ergometers or similar instruments.
- ADiXi — Adixi is a tech-driven business that supports the idea that people and technology may work together. It strives to open doors by utilizing cutting-edge technology, such as artificial intelligence, to promote long-term, sustainable corporate and societal progress.
- EISHIN — EISHIN is a technology company that specializes in pet tech business, recruitment consulting, website creation, and development services.
Fast Track Initiative is a venture capital firm with an exclusive focus on life sciences and healthcare services.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Seed
- Geography: Japan, United States, United Kingdom
Investor stats
- Total investments: 85
- Round size: Seed $345k–$117M; Series A $3M–$51M; Series B $4.7M–$83M
- Lead/follow: 27% lead, 73% follow
- Last fund: May invest from a new fund soon — raised $124M in 2021
Portfolio highlights
- RegCell — RegCell aims to generate novel therapeutic technologies through augmenting or controlling the immune system and our goal is to save patients who suffer from autoimmune diseases and cancer .
- NovAccel — NovAccel operates as a deep tech company, ensure a stable supply of medical radioisotopes.
- Neusignal Therapeutics — Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses.
Sumitomo Mitsui Banking Corporation (SMBC) and its group companies offer a broad range of financial services centered on banking. They are also engaged in the leasing, securities, credit card, investment, mortgage securitization, venture capital and other credit related businesses. The following lists the activities of SMBC, its subsidiaries and affiliates in the various business segments.
Show more...Investment focus
- Industry: Information Technology, Software, Health Care
- Stage:Venture - Series Unknown, Series A, Series B
- Geography: Japan, United States, Singapore
Investor stats
- Total investments: 672
- Round size: Series A $1.1M–$32M; Series B $2.3M–$34M; Venture - Series Unknown $800k–$12M
- Lead/follow: 4% lead, 96% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- LQUOM — QWAVE offers cryptography communication technology.
- Etaily — Etaily provides e-commerce and retail solutions in the Philippines, enabling brands with end-to-end services, from store management to fulfillment.
- Link Therapeutics — Link Therapeutics specializes in developing therapeutic methods for targeting autoantibodies and identifying pathogenic autoantibodies.
UTEC-The University of Tokyo Edge Capital Partners Co., Ltd.. UTEC is a seed/early stage technology focused venture capital firm associated with The University of Tokyo.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Seed, Venture - Series Unknown
- Geography: Japan, United States, India
Investor stats
- Total investments: 215
- Round size: Seed $624k–$12M; Series A $2.3M–$18M; Venture - Series Unknown $2.2M–$13M
- Lead/follow: 37% lead, 63% follow
- Last fund: Likely actively investing — fresh fund, raised $326M in 2025
Portfolio highlights
- Mujin — At Mujin, we design automation platforms to enhance any robot, enable advanced capabilities and lower operating costs.
- RegCell — RegCell aims to generate novel therapeutic technologies through augmenting or controlling the immune system and our goal is to save patients who suffer from autoimmune diseases and cancer .
- United Immunity — Just another WordPress site
DNX Ventues is an early stage VC firm focusing on B2B Startups that are shaping industries and transforming the way we live and work.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: Japan, United States, Canada
Investor stats
- Total investments: 395
- Round size: Seed $482k–$11M; Series A $2.2M–$25M; Series B $2.7M–$38M
- Lead/follow: 29% lead, 71% follow
- Last fund: Likely actively investing — fresh fund, raised $20M in 2026
Portfolio highlights
- Hibot — Hibot offers robotic platforms, and related hardware and software solutions. The company offers robots for hazardous operations as well as for maintenance and inspection of infrastructure, search, and rescue missions. The company was founded in 2004 and is based in Tokyo, Japan.
- Kauli — Kauli is an Online Ad Network Management System pioneered in Japan. Kauli supports Real Time Bidding. This service allows advertisers to place bids for their ads in real time and according to users' characteristics.Kauli frequently reviews Ad Networks so that the Ad Network with the best expected ad revenue will be selected. As aresult, every ad frame always has the best expected ad revenue.
- FLUX — FLUX provide “FLUX Header Bidding Solution” that creates fair competition opportunities and significantly increases advertising revenue within the header bidding server, ad requests are sent to SSPs and ad exchanges all at once, so it is possible to have a pure price competition without prioritization, and to determine the highest bid amount andvalue of the advertising space. I can. Then, the price of the highest bid ad in the header bidding and the ad set in the ad server are competed, and the ad with the higher bid is delivered.
Nissay Capital is a venture capital Company specializing in seed, start-up, growth capital, middle stage, and later stage investment.
Show more...Investment focus
- Industry: Health Care, Software, Medical
- Stage:Venture - Series Unknown, Seed, Series A
- Geography: Japan, United States, Ethiopia
Investor stats
- Total investments: 327
- Round size: Seed $455k–$9.6M; Series A $1.2M–$12M; Venture - Series Unknown $899k–$7M
- Lead/follow: 29% lead, 71% follow
- Last fund: May invest from a new fund soon — raised $92M in 2019
Portfolio highlights
- Indent — Indent creates products that help writers create original works such as novels, manga, screenplays, and game scenarios. They will work to create an environment in which artists can focus on their creations and enjoy sharing their work.
- Spectronix — Spectronics is a development of new technologies and new applications to bring about innovation, focusing on the future of laser technology.
- Zeal Boxing Fitness — Zeal Boxing Fitness combines power of sports with the power of technology to provide a service that allows to enjoy fitness.
UntroD Capital is an R&D-based innovative technology that specializes in social implementation.
Show more...Investment focus
- Industry: Manufacturing, Biotechnology, Health Care
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Japan, Singapore, Austria
Investor stats
- Total investments: 148
- Round size: Seed $316k–$6M; Series A $2.1M–$15M; Venture - Series Unknown $438k–$10M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- JAOPS — JAOPS is dedicated to Operations as a Service and develops software, tools, and services for space mission operations, including data processing, mission planning, context evaluation, anomaly resolution, and real-time mission control and monitoring. The company provides mission operations design, training, and certification for operators, astronauts, and ground segment teams. JAOPS offers products such as Yamcs Gateway, mission control tools, and simulation environments to support spacecraft and lunar rover missions. Its services include turnkey mission control center design and deployment, operational reviews, and operations as a service. JAOPS works with open-source platforms like Yamcs, Grafana, and robotics simulators to support Earth orbit, cislunar, and lunar surface missions.
- Eco-Pork — Eco-Pork is a co-creation solution farm that supports farmers' food productivity improvement. It is connecting the pig and technology, pork ( Pork ) new business ecosystems ( Ecosystem By building a), in the pork growing demand around the world, to get the most out of the food supply capacity is finite.
- Teragen Energy — Teragen Energy develops an energy technology platform based on advanced regenerative solid oxide fuel cells that provide both power generation and energy storage in a single system. The company’s systems generate electricity from external fuels such as natural gas or hydrogen without combustion and can operate in reverse to store power as hydrogen.Teragen designs modular systems that can be scaled from megawatt-scale installations for data centers to deployments for microgrids, renewable projects, and utilities. Its technology is intended to help operators manage variable renewable output, ride through outages, and address daily capacity needs using one device. Teragen focuses on applications including AI and cloud data centers, manufacturing and cold storage facilities, remote communities, and electric grid infrastructure. The platform is positioned to replace separate diesel generators and battery systems by combining fuel-flexible generation and low-cost storage in a compact footprint.
Keio Innovation Initiative (KII) is a venture capital established by Keio University. In order to make more effective use of the research results of Keio University, we aim to contribute to the development of society by creating investment for venture companies that utilize research results and creating new industries.The key to thinking aboutJapan's future growth strategy is to utilize advanced research results of the university. In addition to GDP, in addition to GDP, Japan is the world's third largest R & D exporter in R & D expenses, but as the low growth rate shows, it has a problem in investment efficiency in research and development. There are also reports on the entrepreneurial spirit that is indispensable for creating new industries, with the lowest entrepreneurial activity rate among developed countries.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Seed, Venture - Series Unknown
- Geography: Japan, United Kingdom
Investor stats
- Total investments: 91
- Round size: Seed $826k–$14M; Series A $2.2M–$41M; Venture - Series Unknown $1.6M–$12M
- Lead/follow: 30% lead, 70% follow
- Last fund: May invest from a new fund soon — raised $94M in 2020
Portfolio highlights
- ElleThermo — elleThermo aims to implement Semiconductor-Sensitised Thermal Cells (STCs), an energy conversion technology that can generate electricity from unused waste heat above room temperature.
- Starlight Engine — Starlight Engine develops and commercializes fusion energy power plant technologies.
- Neusignal Therapeutics — Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Global Brain Corporation is a venture capital firm that invests in companies from seed or early to pre-IPO startups. Global Brain has invested in 300+ startups from seed/early to pre-IPO startups and achieved 25 IPOs and 61 M&As as a result of providing hands-on support services and resources to its portfolio startups. Global Brain has managed a pure investment fund as well as multiple corporate venture capital funds partnered together with tier 1 public companies of telecom, real estate development, financial service, beverages, agriculture food, logistics, and electronic devices.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Series A, Series B, Venture - Series Unknown
- Geography: Japan, United States, United Kingdom
Investor stats
- Total investments: 834
- Round size: Series A $1.9M–$31M; Series B $3.4M–$48M; Venture - Series Unknown $602k–$10M
- Lead/follow: 30% lead, 70% follow
- Last fund: Likely actively investing — fresh fund, raised $65M in 2025
Portfolio highlights
- Josys — Stop letting runaway SaaS costs & unsecured SaaS access ruin your day. Josys is the only SaaS Management Platform that provides true 360-degree control.
- Essen — Essen is a technological company that specializes in mobility and data analysis, as well as using data to improve transportation.
- Deeping Source — Real-time Video Analytics based on Data Anonymization. High-accuracy computer vision for large-scale spaces: hypermarkets, shopping malls, convention centers, hospitals, logistics warehouses, construction sites, etc.
Nippon Venture Capital ("NVCC"), established in 1996 as one of the few largest Japanese independent venture capital firms, is destined to undertake the unprecedented task of providing full-range venture capital services in cooperation with major Japanese business leaders and leading companies, which have supported and nurtured various new businesses on their own, as well as proactively developing new venture enterprises.
Show more...Investment focus
- Industry: Health Care, Software, Medical
- Stage:Venture - Series Unknown, Series A, Series B
- Geography: Japan, United States, Indonesia
Investor stats
- Total investments: 205
- Round size: Series A $1.5M–$45M; Series B $3.3M–$33M; Venture - Series Unknown $457k–$12M
- Lead/follow: 17% lead, 83% follow
- Last fund: Likely still investing — raised $15M in 2023
Portfolio highlights
- KUZEN — KUZEN provides enterprise-grade chatbot technologies, especially the bot framework and NLP, via a visual UI without coding. The company is utilizing technology to develop a system that broadens the scope of dialogue. They use technology to provide their customers with next-generation standard procedures that broaden the possibilities ofconversation, resulting in unprecedented business practices.
- United Immunity — Just another WordPress site
- AOI Biosciences — AOI Biosciences is a biotechnology company that creates testing and drug discovery businesses.
Japan Science and Technology Agency is an integrated organization of science and technology that implements science and technology policy in Japan. It handles many projects, including the government’s Science and Technology Basic Plan and knowledge creation. The European Sustainability School ESSSR is the owner of Japan Science and Technology Agency. Japan Science and Technology Agency undertakes its task in a comprehensive manner. It also works to provide a sound infrastructure of science and technology information and raise awareness and understanding of science and technology-related issues in Japan. Japan Science and Technology Agency is headquartered in Tokyo, Japan.
Show more...Investment focus
- Industry: Biotechnology, Medical, Manufacturing
- Stage:Series A, Seed, Venture - Series Unknown
- Geography: Japan
Investor stats
- Total investments: 56
- Round size: Seed $1.7M–$5M; Series A $2.3M–$15M; Venture - Series Unknown $975k–$9.8M
- Lead/follow: 23% lead, 77% follow
Portfolio highlights
- Triorb — The corporate website of TriOrb Inc., revolutionizing production lines with our ball-driven omnidirectional mobility platform.
- ANRis — ANRis is a hybrid drug discovery venture that develops medicines to provide medical care for patients with cancer and genetic diseases.
- Solaris — Solaris commercializes, manufactures, and sells soft robotics using pneumatic artificial muscles. Solaris was founded in 2017 and was headquartered in Tokyo, Japan.
Incubate Fund is an independent early-stage venture capital that specializes in providing capital to technology startups at the seed stage. The firm built a portfolio of over 300 companies in Asia, taking 12 companies to public and 20 companies to M&A exit since 2010.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Japan, United States, India
Investor stats
- Total investments: 395
- Round size: Seed $288k–$7.1M; Series A $1.8M–$20M; Venture - Series Unknown $368k–$9.2M
- Lead/follow: 32% lead, 68% follow
- Last fund: Likely still investing — raised $127M in 2024
Portfolio highlights
- Akari Hosho — Akari Hosho provides a group of trusted professionals, including lawyers and judicial scriveners. Akari Hosho provides a guarantee service.
- Black Cat Carnival — Tell us about anything development-related. Our founder, who launched Niconico Live, SUGAR and GANMA! from scratch, helps with planning, design, development and operations.
- Carbon CryoCapture — Carbon CryoCapture specializes in the carbon dioxide separation systems aimed at creating economically viable, energy-efficient, and genuinely sustainable CO2 separation and recovery technologies. The company is dedicated to deploying cost-effective, efficient systems for CO2 capture that integrate smoothly with current infrastructures, all whileenhancing energy consumption and production. This enables clients to attain zero emissions throughout the development and application of resources.
Coral Capital is a seed stage venture capital firm in Japan.
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Seed, Series A, Series B
- Geography: Japan, United States, Denmark
Investor stats
- Total investments: 111
- Round size: Seed $468k–$8.5M; Series A $3.2M–$41M; Series B $7.6M–$184M
- Lead/follow: 29% lead, 71% follow
- Last fund: Likely actively investing — fresh fund, raised $6M in 2026
Portfolio highlights
- Facilo — Facilo is a real estate communication provider that uses cloud computing to enhance sales and ease transactions of real estate brokerage.
- Albert Invent — 1000’s of scientists, technicians, and engineers across 30+ countries rely on Albert’s end-to-end Cloud Platform to accelerate the innovation of new materials. With Albert, R&D organizations get the data insights and tools needed to increase speed to market, automate regulatory compliance, and heighten the impact of new products.Built fromthe ground up for the chemical and material science industry, the Albert Platform connects R&D processes and creates a single data source of truth across the R&D organization. Augmented with AI, machine learning and a comprehensive materials database, key platform functionality includes inventory, worksheets, workflows, tasks, and more. www.albertinvent.com
- DeltaForesight — DeltaForesight is a business that creates B2B services and goods with a focus on stablecoins and cryptocurrencies. In order to develop solutions that may be applied in Japan, it emphasizes bridging laws, business practices, and technological advancements.
Build your next company with Antler, a global day zero investor enabling exceptional founders to start great companies, from the very beginning. Apply now!
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Pre-Seed, Seed, Series A
- Geography: United States, Singapore, Australia
Investor stats
- Total investments: 2387
- Round size: Seed $158k–$4.6M; Pre-Seed $100k–$600k; Series A $4.1M–$29M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely actively investing — fresh fund, raised $7.5M in 2026
Portfolio highlights
- iiba — Iiba is a geospatial platform that specializes in providing location information related to child-rearing.
- Obud — Obud is a wellness reservation systems that is designed for holistic health and lifestyle management purposes. The company's systems offer a comprehensive suite of tools for booking wellness activities, managing schedules, and accessing curated wellness programs, enabling wellness centers to streamline their operations, enhance userengagement, and promote a balanced and healthy lifestyle.
- Plouton AI —
Mizuho is the venture capital firm affiliated to Mizuho Bank, the second-largest Japanese bank in terms of assets. The firm has headquarters in Tokyo. The firm has ¥49.6 billion JPY under management, focusing on information technology and biotechnology investments. Over 600 Mizuho companies have gone public. According to Nikkei, Mizuho is the fifth-largest venture capital firm in Japan. Mizuho Capital was formed in 2002 by the merger of Fujigin Capital, Tokyo Venture Capital and IBJ Investment. Three firms were subsidiaries of Fuji Bank, Dai-Ichi Kangyo Bank and the Industrial Bank of Japan respectively.
Show more...Investment focus
- Industry: Information Technology, Software, Artificial Intelligence
- Stage:Series A, Venture - Series Unknown, Series B
- Geography: Japan, United States, Singapore
Investor stats
- Total investments: 550
- Round size: Series A $1.4M–$32M; Series B $2.4M–$47M; Venture - Series Unknown $661k–$11M
- Lead/follow: 5% lead, 95% follow
- Last fund: May invest from a new fund soon — raised $92M in 2020
Portfolio highlights
- CaTe — CaTe is based in Tokyo. CaTe develops and manufactures a Digital Therapeutic (DTx) for remote cardiac rehabilitation. Their invention allows heart disease patients to safely and successfully complete cardiac rehabilitation utilizing standing exercise in a confined space, such as at home, without the use of ergometers or similar instruments.
- Flyle — Flyle provides a cloud based platform for product management helping customers to improve productivity & creativity in product development.
- HEARTBEATS — HEARTBEATS builds fan engagement platforms and digital experiences for sports teams, artists, and entertainment brands.
Miyako Capital is the venture capital that manages Kyoto University 2nd Venture Fund (KUVF). The company was founded in 2013 and based in Kyoto & Tokyo, Japan. Investment fields are: 1) Life Science, Biotechnology: Drug creation, regenerative medicine, medical beauty equipment, medical services. 2) Agri-Food: Industrialization, agricultural and fishery products growth-promoting technology, specified health food, health food. 3) Environment, Energy: Alternative energy, and related technologies. 4) IT, Electronics: Web, mobile related devices and application, telecommunication technology, security, consumer and business oriented application, mechatronic, robot. 5) New services utilizing state-of-art technology. Investment stages: Primary investment stages are initial-growth stages of seed and early. However, we aim at all growth stages and make investment in post-IPO portfolio companies as well as public companies that are related with Kyoto University.
Show more...Investment focus
- Industry: Medical, Biotechnology, Information Technology
- Stage:Series A, Seed, Series B
- Geography: Japan, United States, United Kingdom
Investor stats
- Total investments: 54
- Round size: Seed $395k–$19M; Series A $2M–$21M; Series B $3.7M–$150M
- Lead/follow: 19% lead, 81% follow
- Last fund: May invest from a new fund soon — raised $91M in 2019
Portfolio highlights
- Mui Lab — Mui is an aesthetically-pleasing wooden IoT device connected to a cloud service. By accessing information through natural wood, we can rethink a new type of lifestyle.
- Fermelanta — Fermelanta produces rare plant-based ingredients through microbial fermentation. It engineers a cell to build a biosynthetic pathway of target molecules with gene transfer and disruption.
- United Immunity — Just another WordPress site
SBI Investment supports the business development and growth of private venture companies through fund investment. It manages and manages venture capital funds under the management philosophy of becoming a leading company responsible for the creation and development of core industries in the 21st century as a "new industry creator". SBI Investment has invested in a total of 986 companies in the past, of which 169 (17.1% of investment companies) have exited through IPO or M & A.
Show more...Investment focus
- Industry: Software, Information Technology, Financial Services
- Stage:Series B, Series A, Venture - Series Unknown
- Geography: Japan, United States, South Korea
Investor stats
- Total investments: 456
- Round size: Series A $1.9M–$28M; Series B $4.5M–$62M; Venture - Series Unknown $1.3M–$20M
- Lead/follow: 27% lead, 73% follow
- Last fund: May invest from a new fund soon — raised $77M in 2020
Portfolio highlights
- LQUOM — QWAVE offers cryptography communication technology.
- Alxtal — Alxtal is a tech company who optimize the development, design, and manufacturing processes of the manufacturing industry with IT and AI.
- Zerodoor HD — Zerodoor HD specializes in digital transformation in constructing industry.
Tsukuba Institute of Research (筑波総研) is an R&D center owned by housing and wood products group Sumitomo Forestry. The facility develops technologies to make more effective use of wood in a wide range of fields.
Show more...Investment focus
- Industry: Medical, Manufacturing, Health Care
- Stage:Series A, Seed
- Geography: Japan
Investor stats
- Total investments: 10
- Round size: Seed $953k–$1.8M; Series A $2M–$7.1M
- Lead/follow: 10% lead, 90% follow
- Last fund: May invest from a new fund soon — raised $4.5M in 2019
Portfolio highlights
- LIGHTz — LIGHTz delivers a technology transfer and information exchange platform leveraging AI.
- Celaid Therapeutics — Celaid Therapeutics develops technologies and products based on hematopoietic stem cell (HSC) expansion and gene-augmented therapies. The company operates a platform that enables in-vitro propagation of human HSCs without relying on animal-derived components, facilitating scalability, consistency, and cost control. It applies this platform acrossworkflows, including donor/patient cell collection, HSC expansion, cell processing, and gene editing to deliver cell therapy products. Celaid advances pipelines in areas such as blood cancers, genetic disorders, and rare hematologic diseases. Through partnerships and internal research, it seeks to support both reagent/media supply and therapeutic development around HSC-based regenerative medicine.
- Veneno Technologies — Veneno Technologies develops drug candidates for pharmaceutical companies. The company provides services that include the treatment of neurological, cardiovascular, and metabolic diseases, cancer cell proliferation, metastasis, and immune cell regulation.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Osaka University Venture Capital is a venture capital firm that focuses on early-stage ventures in the fields of life innovation, green innovation, and platform technology. The firm was founded in 2014 and based in Osaka, Japan.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Japan
Investor stats
- Total investments: 93
- Round size: Seed $480k–$4.5M; Series A $1.5M–$19M; Venture - Series Unknown $751k–$3.5M
- Lead/follow: 34% lead, 66% follow
- Last fund: May invest from a new fund soon — raised $92M in 2021
Portfolio highlights
- JiMED — JiMED designs & develops AI based brain-computer interface for implant in ALS patients to improve communication.
- LQUOM — QWAVE offers cryptography communication technology.
- RegCell — RegCell aims to generate novel therapeutic technologies through augmenting or controlling the immune system and our goal is to save patients who suffer from autoimmune diseases and cancer .
Japan Finance provides a diversified portfolio of financial services to the small and medium enterprise sector.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Debt Financing, Seed, Venture - Series Unknown
- Geography: Japan, Kenya, Hong Kong
Investor stats
- Total investments: 390
- Round size: Seed $282k–$1.8M; Debt Financing $212k–$13M; Venture - Series Unknown $635k–$11M
- Lead/follow: 32% lead, 68% follow
Portfolio highlights
- Facilo — Facilo is a real estate communication provider that uses cloud computing to enhance sales and ease transactions of real estate brokerage.
- Indent — Indent creates products that help writers create original works such as novels, manga, screenplays, and game scenarios. They will work to create an environment in which artists can focus on their creations and enjoy sharing their work.
- Intentia — Intentia is a technology startup that specializes in developing and implementing operational support AI agents tailored for the manufacturing and wholesale sectors. The company designs AI tools that seamlessly integrate into existing workflows instead of completely replacing legacy IT architecture.
MSIVC is a venture capital firm that invests in Japanese and global startups scaling to IPO. It focuses on startups in verticals of Fintech, SaaS, Healthcare, AI, E-Commerce, Foodtech, and Environment etc.
Show more...Investment focus
- Industry: Software, Information Technology, Manufacturing
- Stage:Venture - Series Unknown, Seed, Series A
- Geography: Japan, United States, India
Investor stats
- Total investments: 330
- Round size: Seed $482k–$12M; Series A $1.2M–$16M; Venture - Series Unknown $957k–$8.3M
- Lead/follow: 15% lead, 85% follow
- Last fund: Likely still investing — raised $88M in 2021
Portfolio highlights
- 9lione — 9lione is a cloud drug management system that can perform complicated drug management easily. It uses optical character recognition technology (OCR) whereas information can be read simply by taking a prescription, and drug inventory lists are automatically created and updated. It was established on August 8, 2018, and is headquartered in Tokyo,Japan.
- Peco Free — Peco Free is a school meal pre-order service that is selected using a smartphone.
- Smart Craft —
REVIC is an organization that supports the business revitalization of small and medium-sized enterprises and regional revitalization in order to revitalize Japan's regional economy and contribute to strengthening the foundation of credit order. It was established in March of the year by reorganizing its predecessor, the Enterprise TurnaroundInitiative Corporation. It supports the business feasibility evaluation conducted by regional financial institutions to provide solutions that match the life stages of local companies, based on the current situation and issues of the regional economy and industry.
Show more...Investment focus
- Industry: Manufacturing, Health Care, Medical
- Stage:Venture - Series Unknown, Seed, Series C
- Geography: Japan
Investor stats
- Total investments: 41
- Round size: Seed $15k–$8.1M; Series C $4.2M–$27M; Venture - Series Unknown $388k–$6.3M
- Lead/follow: 29% lead, 71% follow
- Last fund: May invest from a new fund soon — raised $4.8M in 2018
Portfolio highlights
- Provigate — PROVIGATE is a provider of bio-transistor sensor technologies in Japan.The company's technologies are able to measure dynamic changes with the help of perception-broadening sensors, enabling individuals to change their habits for health
- Japan Agriculture — Exportation of Japanese agricultural products is currently small in volume. While Japanese farmers aspire to export their products to foreign countries for more people to enjoy and local consumers universally share the positive perception of the quality of Japanese agricultural products, issues such as price, communication, and logistics hinder theexpansion of exportation.They aim to solve these issues and satisfy the needs of both Japanese farmers and global consumers which are so clearly evident but devastatingly unmet.
- KOALA Tech — Koala Tech Inc. is an innovative high-tech startup company, whose goal is to pioneer practical applications of the world's first organic semiconductor laser diode that has been realized in the Center for Organic Photonics and Electronics Research (OPERA) at Kyushu University.
DBJ Capital Co., Ltd. was founded in June 2010 through the integration of two venture capital firms of the DBJ Group, New Business Investment Co., Ltd. and Intellectual Properties Development & Investment, Inc. We are a wholly-owned subsidiary of Development Bank of Japan Inc. At DBJ Capital, we focus on venture firms which use new technologies and business models to grow and compete on the global market, regardless of their industry or scale. To meet the particular needs of each client, we mobilize the entire DBJ Group to arrange the best investment solutions, ranging from growth-spurring equity investment to financing schemes drawing on DBJ's vast networks. We also assist in venture start-ups. Our value enhancement team provides the kind of comprehensive, hands-on support needed to commercialize outstanding intellectual property and technologies developed by firms, research labs, and universities, and to carve out a place for them in the market. DBJ Capital will continue to play in a part in Japan's economic revival - by helping the firms we invest in to grow, and by encouraging the creation of new industries in Japan.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series A, Venture - Series Unknown, Series B
- Geography: Japan, United States, Australia
Investor stats
- Total investments: 168
- Round size: Series A $2.4M–$17M; Series B $4.6M–$34M; Venture - Series Unknown $887k–$9.5M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- Facilo — Facilo is a real estate communication provider that uses cloud computing to enhance sales and ease transactions of real estate brokerage.
- MOT — MOT manages and supports the business activities of writers, particularly manga artists, while also operating “Kakikomi,” an online manga school that provides aspiring artists with education, guidance, and practical training to develop their creative skills.
- Spectronix — Spectronics is a development of new technologies and new applications to bring about innovation, focusing on the future of laser technology.
Mobile Internet Capital (MIC) keeps up on the latest developments of Mobile Internet technologies and services at a high level, and continues to be a venture capital with both technical expertise and execution capability.
Show more...Investment focus
- Industry: Software, Information Technology, Mobile
- Stage:Series A, Venture - Series Unknown
- Geography: Japan, United States, China
Investor stats
- Total investments: 128
- Round size: Series A $893k–$50M; Venture - Series Unknown $547k–$3.4M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — raised $99M in 2019
Portfolio highlights
- Wasimil — Wasimil is a tool for customers in the hospitality sector. In addition to increasing sales inside the hotel system, it increases automation and efficiency in hotel management. It is a centrally managed platform for hotel management that automates all hotel departments' daily activities and enhances the number of hotel bookings.
- Trash Technologies — Trash Technologies is an AI-powered sustainability company focusing on sourcing recycled materials with cost-offsetting benefits.
- Bridgesmile Corporation — Bridgesmile operates an on-site installation and replacement service platform for consumers and businesses. Its service, The Butler Next Door, enables customers to arrange technician visits for products purchased through e-commerce sites and manufacturers. Supported categories include dash cameras, security cameras, smart locks, and air conditioners. The platform coordinates online reservations with offline installation work and provides pricing and service coverage information. Bridgesmile also develops and operates the service for business partners, including e-commerce companies and manufacturers.
Welcome to ASICS Ventures website
Show more...Investment focus
- Industry: Health Care, Medical, Artificial Intelligence
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Japan, India, Canada
Investor stats
- Total investments: 21
- Round size: Seed $1.8M–$3.3M; Series A $918k–$15M
- Lead/follow: 29% lead, 71% follow
- Last fund: May invest from a new fund soon — raised $27M in 2016
Portfolio highlights
- RebuilderAI — A new way to bring imagination into the real world
- Pickleball One — Pickleball one is to become an enabler of the pickleball industry , spreading the joy of "Fun as one" to the world.
- Digital Entertainment Asset — DEA is an Entertainment Solution Company that continues to propose next-generation solutions to challenges through Web3, gaming mechanisms, and the utilization of DePIN.
IT-Farm is a venture capital firm which specializes in seed, start-up, and early stage companies. It primarily invests in mobile, big-data, connected car, IoT, OTT service, Helth care, Bio Tech and other IT industries. The firm actively invests in SF bay area and Japan, as well as other geometries including Asia and Europe. We support portfolio companies, especially on the partnership with Japanese enterprises.
Show more...Investment focus
- Industry: Software, Health Care, Medical
- Stage:Seed, Series A, Series B
- Geography: United States, Japan, Germany
Investor stats
- Total investments: 135
- Round size: Seed $1M–$7.5M; Series A $1.6M–$16M; Series B $2.5M–$36M
- Lead/follow: 10% lead, 90% follow
- Last fund: May invest from a new fund soon — last raise in 2021
Portfolio highlights
- Ubitus — As cloud gaming enablers, Ubitus' GPU virtualization, Streaming technology and hybrid cloud deployment can serve different kinds of solutions for Telco, Game companies to quick enter cloud gaming market. Moreover, Ubitus provide Global distribution and New Media content solution for new media studio and fashion brand to help them distribute rich media contents worldwide.
- BitBiome — BitBiome is a biotechnology company focused on analyzing microbial genomes and discovering enzymes and proteins that can be applied across industries such as pharmaceuticals, food production, and sustainable manufacturing. The company uses single-cell microbial sequencing technology to study microbes that are difficult to culture throughconventional laboratory methods, enabling the creation of a large microbial genome database called bit-GEM. Its platform supports enzyme discovery, genome analysis, and bioengineering efforts aimed at developing bio-based alternatives for industrial processes. bitBiome also works with academic institutions and commercial partners on research projects involving areas such as biodegradable materials, biomass conversion, and pharmaceutical ingredient synthesis. The company positions microbes as a resource for advancing the bioeconomy by providing tools and data that support biotechnology research and industrial applications.
- POPS Worldwide — POPS Worldwide is the leading digital entertainment company in Southeast Asia. With over 4 billion monthly views of its music and entertainment content, POPS is the fastest growing digital entertainment media company with hundreds of artists, content creators and partners from broadcast television, publishing and production in the POPS Network.POPS also produces a wide variety of original content for its industry-leading owned and operated channels like POPS Music, POPS Kids, POPS TV, Beauty Me, HerVoice and CoolTV that target highly sought after demographics: teens, kids, women and men.
The University of Tokyo IPC is a company responsible for expanding the innovation ecosystem of the University of Tokyo. Accelerate global innovation from the University of Tokyo through three activities: start-up support, investment business, and corporate innovation support.It was established as a wholly-owned subsidiary of the University ofTokyo in 2016 with the enforcement of the revised law of the Industrial Competitiveness Enhancement Law, which is the basis law. The investment targets of the Todai IPC are venture companies that utilize the research results and human resources of the University of Tokyo, but they also make FOF (fund of funds) investments in funds managed by some private venture capital companies. In 2019, it started a consortium-type incubation program (University of Tokyo IPC 1stRound) to support the establishment and financing of Tokyo University-related ventures.
Show more...Investment focus
- Industry: Biotechnology, Medical, Manufacturing
- Stage:Series A, Series B
- Geography: Japan, United States, United Kingdom
Investor stats
- Total investments: 65
- Lead/follow: no public data
Portfolio highlights
- Issin — Issin manufactures bath mats that can measure weight and automatically record daily weight changes on your smartphone.
- RoboTruck — RoboTruck develops autonomous driving technologies for huge trucks, as well as practical applications.
- Leading Mark — Leading Mark, a rising human resources startup in Japan. Leading Mark is branching out into mid-career and international hiring. It currently has a one-man team in China working to bring the top Japanese-speaking Chinese students to domestic companies. He also touts his startup’s focus on the average job seeker. “We want to make sure that the usersget the info that he or she needs the most,” he says. Large scale, legacy players can sometimes prioritize the needs of the hiring company, and their commission, over the needs of applicants themselves. This leads to frustration and short-circuited careers.
Capital Medica Ventures is a venture capital firm based in Tokyo, Japan with a focus on startups in the healthcare industry.Capital Medica Ventures is a venture capital that operates a venture fund specializing in the healthcare field. It is the only healthcare-specialized VC in Japan that can provide 30 medical institutions as a business trialfield.
Show more...Investment focus
- Industry: Health Care, Medical, Software
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Japan
Investor stats
- Total investments: 19
- Round size: Seed $91k–$1.1M; Series A $1.5M–$51M; Venture - Series Unknown $1.5M–$11M
- Lead/follow: 16% lead, 84% follow
- Last fund: May invest from a new fund soon — raised $12M in 2018
Portfolio highlights
- A-SEEDS — A-SEEDS, an innovative biotech company sprouted from Shinshu University, is dedicated to pioneering advanced treatments for life-threatening cancers. Harnessing the potential of non-viral genetic engineering, our cutting-edge immune cell therapy opens up new horizons of hope for patients seeking effective and transformative solutions.
- Do. Sukasu — Do. Sukasu is a software company that specializes in the development of visual space perception ability for brain science approaches.
- HEAL-lll — HEAL-lll is a multifaceted firm that merges healthcare, technology, and gamification to promote individual and organizational well-being.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!ITOCHU Technology Ventures (ITV), based in Tokyo, is the venture capital arm of ITOCHU Corporation. ITOCHU is one of the world's largest corporations with offices in over 80 countries and operations that cover a broad spectrum of industries. ITV's mission is to invest and help build leading information technology companies by leveraging a vast array of resources both domestically and internationally throughout ITOCHU and its group companies. The ITOCHU group has a long history of funding information technology companies with successes including Siebel Systems, NVIDIA, Openwave and Aruba Networks. Current portfolio includes, Box, Fab, Ooyala, WHILL, Tokyo Otaku Mode, etc.
Show more...Investment focus
- Industry: Software, Information Technology, E-Commerce
- Stage:Series A, Series B, Venture - Series Unknown
- Geography: Japan, United States, Belgium
Investor stats
- Total investments: 154
- Round size: Series A $2M–$38M; Series B $3.4M–$37M; Venture - Series Unknown $1.3M–$36M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — raised $93M in 2019
Portfolio highlights
- THE PHAGE — The phage is a medical device company that focuses on developing AI technology to predict postprandial blood glucose levels.
- CMerTV — CMer TV is a platform that connects advertisers with newspapers, magazines, and specialized media by video
- Link Therapeutics — Link Therapeutics specializes in developing therapeutic methods for targeting autoantibodies and identifying pathogenic autoantibodies.
THVP is a venture capital corporation for startup innovation. It was established in 2015 and is based in Nagoya, Japan.
Show more...Investment focus
- Industry: Manufacturing, Medical, Biotechnology
- Stage:Venture - Series Unknown, Seed, Series A
- Geography: Japan, China
Investor stats
- Total investments: 54
- Round size: Seed $271k–$2.7M; Series A $1M–$7.9M; Venture - Series Unknown $459k–$8.8M
- Lead/follow: 50% lead, 50% follow
- Last fund: May invest from a new fund soon — last raise in 2020
Portfolio highlights
- Koeda — KOEDA is researching and developing medical devices that are safe, painless, and easy to use for acute cholecystitis. KOEDA will transform the management of cholecystitis. So far, endoscopic ultrasound-guided gallbladder drainage (EUS-GBD) has been a notably difficult procedure carried out by skilled doctors at specific advanced centers. Althoughinserting a tube into the gallbladder is less invasive, it is complex, and there may be concerns regarding bile leakage. By combining clinical expertise with precision engineering, KOEDA addresses a clearly defined medical need in a growing global market and is currently moving forward on schedule for regulatory clearance and commercialization.
- Scohia Pharma — Scohia Pharma is a biotech venture that will have both substantial research and development resources and be nimble enough to make decisions quickly, will strive to improve patient quality of life by providing patients and healthcare professionals with new therapeutic medications for renal, metabolic.
- SiccaNova Therapeutics — SiccaNova Therapeutics is a Japanese biopharmaceutical company dedicated to treating sicca (dryness) related medical conditions. The company’s lead drug candidate, XF8302, is a novel, small-molecule M3 muscarine receptor Positive Allosteric Modulator (M3 PAM). Developed initially for dry mouth in Sjögren’s syndrome patients, the drug enhancesnatural acetylcholine signaling to stimulate salivation without the systemic side effects common in traditional agonists.
QB Capital is make equity investments in venture companies.
Show more...Investment focus
- Industry: Manufacturing, Medical, Biotechnology
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Japan, Singapore, United States
Investor stats
- Total investments: 55
- Round size: Seed $633k–$2.9M; Series A $585k–$14M; Venture - Series Unknown $732k–$12M
- Lead/follow: 22% lead, 78% follow
- Last fund: May invest from a new fund soon — raised $26M in 2015
Portfolio highlights
- Equmenopolis — Equmenopolis is an information services company that specializes in conversational AI agent platforms and application developments.
- Mechano Cross — Mechano Cross is a mechanical company that offers mechanochemical organic synthesis technology for solution reactions.
- Surv Biopharma — Surv Biopharma develops a drug discovery platform that facilitates research and development of veterinary drugs and pharmaceutical products.
Real Tech Japan is a venture capital firm that seeks to invest in innovative R&D technology companies. Realtech Fund is a joint venture between the Ministry of Economy, Trade, and Industry and NEDO (New Energy and Industrial Technology Development Organization). The firm was founded in 2014 and based in Tokyo, Japan.
Show more...Investment focus
- Industry: Manufacturing, Biotechnology, Robotics
- Stage:Venture - Series Unknown, Seed, Series A
- Geography: Japan, Singapore, Austria
Investor stats
- Total investments: 79
- Round size: Seed $316k–$5M; Series A $2.1M–$21M; Venture - Series Unknown $421k–$10M
- Lead/follow: 41% lead, 59% follow
- Last fund: May invest from a new fund soon — last raise in 2020
Portfolio highlights
- Ashirase — Ashirase is a developer of a walking navigation system for the visually challenged. The company assists visually impaired people in walking independently. This also allows the user to have more attention to spare for audible warnings in their environment. It includes voice input and guidance via a smartphone app. A vibration interface is attachedto their shoes.
- Ken Robotec — Ken Robotec provides labor-saving solutions that promote productivity improvement and reduce the burden on workers at construction sites. The company contributes to the evolution and development of the construction industry. The objective of Ken Robotec is to create a joyful construction site where robots and humans may collaborate.
- MaterialGate — MaterialGate focuses on single-molecule dielectrics, developing technologies for devices with better electronic characteristics.
FFG Venture Business Partners is a large-scale enterprise that offers in traditional regional bank venture capital.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Series A, Venture - Series Unknown, Seed
- Geography: Japan, Indonesia, United States
Investor stats
- Total investments: 89
- Round size: Seed $706k–$50M; Series A $1.2M–$8.4M; Venture - Series Unknown $547k–$10M
- Lead/follow: 10% lead, 90% follow
- Last fund: May invest from a new fund soon — raised $46M in 2020
Portfolio highlights
- Josan-shes — Josan shes is web start up that offers nursing service to women and babies.
- InsightX — InsightX is a technology platform focused on empowering businesses by simplifying complex processes and enabling smarter, more personalized user experiences.
- DeltaForesight — DeltaForesight is a business that creates B2B services and goods with a focus on stablecoins and cryptocurrencies. In order to develop solutions that may be applied in Japan, it emphasizes bridging laws, business practices, and technological advancements.
Angel Bridge is a angel investor groups in Japan and provide high quality and abundant funds to excellent companies.
Show more...Investment focus
- Industry: Information Technology, Software, Consulting
- Stage:Series A, Seed, Series B
- Geography: Japan
Investor stats
- Total investments: 78
- Round size: Seed $648k–$10M; Series A $2.5M–$19M; Series B $6.5M–$47M
- Lead/follow: 40% lead, 60% follow
- Last fund: May invest from a new fund soon — raised $10M in 2019
Portfolio highlights
- Facilo — Facilo is a real estate communication provider that uses cloud computing to enhance sales and ease transactions of real estate brokerage.
- PeopleX — PeopleX encourages and assists employees in their professional development.
- Power Laser — Power Laser is a startup company that offers a range of power laser technologies and applications. The company develops high-power laser systems, related components, and software for advanced industrial and scientific applications. Its mission, “Power lasers open the future,” reflects its focus on next-generation photonics and precision laserinnovation for manufacturing and research sectors.
Senshu Ikeda Capital offers financial consultancy services.
Show more...Investment focus
- Industry: Software, Manufacturing, Internet
- Stage:Venture - Series Unknown, Series A, Seed
- Geography: Japan
Investor stats
- Total investments: 68
- Round size: Seed $395k–$3.8M; Series A $1.9M–$17M; Venture - Series Unknown $443k–$10M
- Lead/follow: 4% lead, 96% follow
- Last fund: May invest from a new fund soon — raised $11M in 2019
Portfolio highlights
- JiMED — JiMED designs & develops AI based brain-computer interface for implant in ALS patients to improve communication.
- Molmir — Molmir is a biotech company that conducts research and develops treatments for intractable diseases based on sensing technology.
- Eight Knot — Eight Knot is a developer of autonomous navigation systems intended for water mobility. They provide autonomous ship maneuvering technology using robotics, enabling customers with water-on-demand transportation using environment-friendly EV robotic boats.
MedVenture Partners invests in seed to early stage projects and start-ups in the life science field focusing mainly on medical devices.
Show more...Investment focus
- Industry: Medical Device, Health Care, Manufacturing
- Stage:Series B, Series A, Venture - Series Unknown
- Geography: Japan, United States
Investor stats
- Total investments: 18
- Round size: Series A $931k–$11M; Series B $2.4M–$10M; Venture - Series Unknown $1.3M–$4.4M
- Lead/follow: 56% lead, 44% follow
- Last fund: May invest from a new fund soon — raised $9.2M in 2019
Portfolio highlights
- A-Wave — A-Wave is a manufacturing company that develops and markets medical devices, pharmaceuticals, computer software, and hardware.
- Quali — Quali is dedicated to developing innovative products and solutions that support microsurgery, with the goal of addressing critical challenges in the medical field and improving patient outcomes and overall quality of life.
- Avisi Technologies — Avisi Technologies is developing a nanotechnology-enabled defense against blindness from glaucoma.
Venture capital firm located in Kyushu (the westernmost of Japan’s four main islands). They believe that the fundamental challenge facing the local economy is the lack of employment diversity. Although it is a simple example, it is easier to understand if you compare the Tokyo metropolitan area with Kyushu and list the companies that can achieve annual income of 10 million yen at the age of 30 (probably with a head office in Kyushu Most companies with the highest annual income will be infrastructure company
Show more...Investment focus
- Industry: Information Technology, Apps, Software
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Japan, United States
Investor stats
- Total investments: 49
- Round size: Seed $233k–$5.4M; Series A $1.3M–$21M; Venture - Series Unknown $279k–$9.9M
- Lead/follow: 8% lead, 92% follow
- Last fund: May invest from a new fund soon — raised $23M in 2020
Portfolio highlights
- Foodcam — Foodcam aims to build a comprehensive overseas distribution infrastructure for Japanese food products, enabling manufacturers and suppliers to efficiently expand into international markets through streamlined logistics, supply chain management, and global distribution solutions.
- EUV Photon — EUV Photon is an irradiation services company that conducts processing, evaluation, and measurement of materials for EUV lights.
- 12 Pharmacy — 12 Pharmacy is a pharmaceutical company that specializes in manufacturing and providing medicines and services for veterinary hospitals.
Kyogin Lease & Capital is an investment firm that specializes in the leasing, stock and bond investment and public offering consulting.
Show more...Investment focus
- Industry: Manufacturing, Medical, Information Technology
- Stage:Series A, Venture - Series Unknown, Seed
- Geography: Japan
Investor stats
- Total investments: 36
- Round size: Seed $91k–$3.8M; Series A $1.1M–$16M; Venture - Series Unknown $90k–$9M
- Lead/follow: 8% lead, 92% follow
- Last fund: May invest from a new fund soon — raised $9M in 2019
Portfolio highlights
- TSK Corporation — TSK is a manufacturing company that develops organic synthesis technology to supply innovative and long-lasting catalysts to industries. The company develops and manufactures iron catalysts that are used in the production of agrochemicals, semiconductors, and pharmaceuticals, giving enterprises the option of switching from palladium catalysts tomore environmentally friendly iron catalysts.
- IKOU — IKOU is an inclusive brand for babies and children that creates products valued by all users. The company's featured products include portable seats, bibs, and children's clothing products along with online services.
- Towing — Towing is an agricultural company that provides farming, manufacturing, and recycling services.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Fujifilm develops and sells consumer products and business products related to photography. Fujifilm Holdings Corporation is a Japanese multinational photography and imaging company. The company serves various industries, including medical, graphic arts, optics, enterprise storage, motion picture, and photography.The company’s consumer productsare categorized as digital cameras and accessories, film photography, Instax photography, and binoculars. Its business products are categorized as medical systems, Fujinon endoscopy, microfilm, data storage, graphic arts and printing, professional video, optical devices, specialty chemicals, printing imaging colorants, and more. Color films, digital cameras, photofinishing equipment, color papers, photofinishing chemicals, medical imaging equipment, graphic arts equipment and materials, flat panel displays, and photocopiers and printers are some products developed by Fujifilm USA.Fujifilm USA is based in Minato-ku, Tokyo, Japan.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Venture - Series Unknown, Corporate Round
- Geography: Japan, United States, China
Investor stats
- Total investments: 25
- Round size: Series A $3.3M–$250M; Corporate Round $1.3M–$1.7B; Venture - Series Unknown $2.9M–$36M
- Lead/follow: 28% lead, 72% follow
Portfolio highlights
- Ripcord — Ripcord turns documents into powerful data. As a disruptor in the document intelligence market, Ripcord’s AI-driven platform harnesses proprietary robotics, generative AI, and cloud software to digitize and accurately derive vital information from paper and digital documents. Founded out of NASA research, Ripcord is backed by leading investorsincluding Kleiner Perkins, Google Ventures, Icon Ventures, Lux Capital, MUIP, and Apple co-founder Steve Wozniak.
- Rapidus — Rapidus is an Electronic component research, development, design, production, and sales that includes semiconductor elements and integrated circuits. Environmentally friendly, energy-saving semiconductors and semiconductor manufacturing technology are being researched and developed. Human resource development and training for the semiconductorsector.
- VALANX Biotech — VALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development.
MTG Ventures is the corporate venture capital arm of MTG that invests in beauty and wellness tech, food tech, and sports tech sectors.
Show more...Investment focus
- Industry: Health Care, Manufacturing, Marketing
- Stage:Seed, Series A
- Geography: Japan
Investor stats
- Total investments: 43
- Round size: Seed $531k–$16M; Series A $2.6M–$142M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- Dwilar — Dwilar is a proptech company that provides AI-powered leasing solutions tailored for international buyers seeking property. Their platform enables users to design flexible lease agreements with the option to own, allowing for property customization and renovation during the lease period. By avoiding dollar-denominated loans, it minimizes currencyexchange risks and offers a streamlined and personalized path to property acquisition.
- Synflux — Synflux is a fashion lab comprising of fashion designers, software engineers & architects focused on fashion industry.
- EF Polymer — EF Polymer Private Limited providing 100% Organic and fully Biodegradable Super Absorbent Polymer cum Fertilizer to reduce Water and Fertilizer requirement for your plant. Let's grow organically.
KSP, Inc. is the core business entity responsible for operating the Kanagawa Science Park (KSP) and has accepted the challenge of creating new industries through the support, development, and incubation of venture businesses. We provide a variety of business support services that best meet the needs of venture businesses in each stage of theirbusiness growth, ranging from the processes of startup and growth to public offerings. Several hundreds of new startup companies have been created and nurtured since its foundation. An incubation manager (IM) acts as a coordinator and provides a variety of support services to a venture company to help them successfully launch and develop their new business, such as offering individual consultations and a variety of information or advice. KSP, Inc. is well poised to cope with the varying needs of new ventures for highly sophisticated, specialized tasks by offering a business school, business support center, business matching services, and investment funds.The public sector, such as the Kanagawa prefectural government, Kawasaki city government, and the Development Bank of Japan, Inc., has an equity participation in KSP, thus playing a vital role in the deployment of local industrial development policy.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B
- Geography: Japan
Investor stats
- Total investments: 36
- Lead/follow: no public data
Portfolio highlights
- 3DC — 3DC develops and manufactures a new carbon material, graphene meso sponge (GMS), for electrodes in next-generation batteries, capacitors, fuel cells and other energy storage and generation devices.
- THE PHAGE — The phage is a medical device company that focuses on developing AI technology to predict postprandial blood glucose levels.
- Mira Robotics — Mira Robotics is a software based company provide services that can robots in various fields.
Future Venture Capital Co., Ltd. is a venture capital firm specializing in early stage investment. The firm invests in diversified investment in a broad range of industrial sectors. It seeks to invest in Japan. The firm prefers to be the lead investor in its portfolio companies. Future Venture Capital Co., Ltd. was founded in 1998 and is based inKyoto, Japan with offices in Tokyo, Aomori, Iwate, Yamagata, Kanazawa, Mie, Sakai, Kobe, and Ehime.
Show more...Investment focus
- Industry: Manufacturing, Health Care, Information Technology
- Stage:Seed, Venture - Series Unknown
- Geography: Japan, United States, Myanmar
Investor stats
- Total investments: 154
- Round size: Seed $338k–$16M; Venture - Series Unknown $186k–$3.5M
- Lead/follow: 14% lead, 86% follow
- Last fund: May invest from a new fund soon — raised $36M in 2020
Portfolio highlights
- Sinumy — Sinumy develops touchless identity authentication technology and high-speed, high-precision position measurement technology.
- Dioseve — Dioseve is providing novel possibilities for all life.
- Flosfia — FLOSFIA is a spin-off from a research of Kyoto University, specializing in film-formation by mist chemical vapor deposition (CVD). Making use of physical properties of gallium oxide (Ga2O3), FLOSFIA has devoted to development of low-loss power devices.
Genesia Ventures is a venture capital firm focused on seed/early stage startups in Japan and Southeast Asia. Since it's inception in Dec 2016, Genesia Ventures has invested in over 90 companies in Japan, Indonesia, Vietnam, Singapore and the US. Genesia Ventures invests in various sectors: SaaS, marketplace, Media, Finance, Insurance, RealEstate, Healthcare, Medical, Travel, Education, Manufacturing, Construction, HR, Agriculture, Sports, Retail, Entertainment, etc.
Show more...Investment focus
- Industry: Information Technology, Software, Artificial Intelligence
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Japan, Vietnam, Indonesia
Investor stats
- Total investments: 241
- Round size: Seed $462k–$5.7M; Series A $1.2M–$11M; Venture - Series Unknown $404k–$2.1M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely still investing — raised $110M in 2022
Portfolio highlights
- THE PHAGE — The phage is a medical device company that focuses on developing AI technology to predict postprandial blood glucose levels.
- AI Mage — AI Mage is an IT company that provides AI solutions for anime production business industries.
- Umami United — Umami United is a plant-based food brand with unique focus on Japanese food technologies and traditional ingredients to make delicious and healthy food to unite people at one table. The wide lineups are designed to be vegan-friendly, buddhist friendly, and halal friendly for all.
Honda Motor Co Ltd is a Japanese public multinational corporation primarily known as a manufacturer of automobiles and motorcycles. It distributes motorcycles, scooters, all-terrain vehicles, side-by-sides, and more in the United States.The company conducts sales, marketing, and operational activities for cars, trucks, sport utilityvehicles, automobile parts and accessories, engines, generators, lawnmowers, tillers, trimmers, multi-purpose utility vehicles, outboard motors, pumps, scooters, and snowblowers through authorized Honda dealers.Honda Automobiles is also specialized in the design and development of race engines, chassis and performance parts, and technical support services.Honda Automobiles was founded in 1959 and is based in Torrance, California. It operates as a subsidiary of Honda Motor Co., Ltd.
Show more...Investment focus
- Industry: Manufacturing, Renewable Energy, Energy
- Stage:Corporate Round, Series A, Series C
- Geography: United States, Japan, Germany
Investor stats
- Total investments: 40
- Round size: Series A $3.3M–$64M; Series C $22M–$99M; Corporate Round $6.9M–$2B
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- Helm.ai — Explore Helm.ai's AI software for high-end ADAS through Level 4 autonomous vehicles. Helm.ai offers a full suite of full-stack AI software, foundation models, and generative AI development and validation tools for production-bound projects.
- PathAhead — PathAhead develops materials for road and infrastructure construction using underutilized desert sand. The company’s core product, Rising Sand, is an artificial aggregate engineered to provide high durability for paved roads. PathAhead focuses on improving road longevity and performance while using locally available sand resources. Its solutionstarget public infrastructure projects and private developers in regions with growing transportation networks. The organization works with partners including corporate backers to advance material development and deployment.
- Rapidus — Rapidus is an Electronic component research, development, design, production, and sales that includes semiconductor elements and integrated circuits. Environmentally friendly, energy-saving semiconductors and semiconductor manufacturing technology are being researched and developed. Human resource development and training for the semiconductorsector.
Daiwa Corporate Investment is a private investment firm of Daiwa Securities Group that has been engaged in overseas VC investments by taking advantage of an extensive business network in Japan and foreign countries, long experience and professional knowledge, and by supporting the growth of a number of overseas portfolio companies and their stock exchange listings.
Show more...Investment focus
- Industry: Software, Manufacturing, Health Care
- Stage:Venture - Series Unknown, Series A, Seed
- Geography: Japan, United States, France
Investor stats
- Total investments: 144
- Round size: Seed $310k–$1.3M; Series A $1.1M–$6.9M; Venture - Series Unknown $910k–$9.2M
- Lead/follow: 19% lead, 81% follow
- Last fund: May invest from a new fund soon — raised $90M in 2018
Portfolio highlights
- NovAccel — NovAccel operates as a deep tech company, ensure a stable supply of medical radioisotopes.
- AstroX — AstroX is a private space startup company that develops satellite launch vehicles for space development. It utilizes the rockoon method for developing launch vehicles and small rockets to help clients easily use space.
- Sonire Therapeutics — SONIRE Therapeutics Inc. (SONIRE) is working on a next-generation high-intensity focused ultrasound (HIFU) therapy system that will employ acoustic engineering (ultrasound) technologies developed through cutting-edge academic research. SONIRE has been working on a next-generation high-intensity focused ultrasound (HIFU) treatment system as a noveltherapeutic modality with the goal of giving cancer patients and their families a new future.
Higegin Capital is a venture capital firm.
Show more...Investment focus
- Industry: Medical, Biotechnology, Software
- Stage:Series A, Series B, Venture - Series Unknown
- Geography: Japan
Investor stats
- Total investments: 27
- Round size: Series A $1.2M–$9.1M; Series B $3.8M–$17M; Venture - Series Unknown $279k–$13M
- Lead/follow: 4% lead, 96% follow
- Last fund: May invest from a new fund soon — raised $9.2M in 2020
Portfolio highlights
- Molmir — Molmir is a biotech company that conducts research and develops treatments for intractable diseases based on sensing technology.
- EUV Photon — EUV Photon is an irradiation services company that conducts processing, evaluation, and measurement of materials for EUV lights.
- Restore Vision — Restore Vision is a startup based in Japan aiming to develop a visual restoration gene therapy.
Sumitomo Mitsui Banking Corporation offers a broad range of financial services centered on banking. They are also engaged in leasing, securities, credit card, investment, mortgage securitization, venture capital, and other credit-related businesses. The following lists the activities of SMBC, its subsidiaries, and affiliates in the various business segments. It is a wholly-owned subsidiary of Sumitomo Mitsui Financial Group. As of the year 2009, SMBC was the second largest bank in Japan in terms of assets.
Show more...Investment focus
- Industry: Energy, Financial Services, Renewable Energy
- Stage:Debt Financing, Post-IPO Debt, Venture - Series Unknown
- Geography: Japan, United States, India
Investor stats
- Total investments: 331
- Round size: Post-IPO Debt $93M–$3B; Debt Financing $3.4M–$1.3B; Venture - Series Unknown $1M–$54M
- Lead/follow: 23% lead, 77% follow
Portfolio highlights
- Facilo — Facilo is a real estate communication provider that uses cloud computing to enhance sales and ease transactions of real estate brokerage.
- GX MINERALS — GX MINERALS develops, manufactures, and markets high-performance fillers that promote decarbonization.
- Crux AI — Crux AI is a integrated AI infrastructure firm founded to overcome the physical and operational limits on meaningful AI goals.
D4V (Design for Ventures) is a Tokyo-based early-stage venture capital firm that invests in disruptive, consumer, and enterprise technology startups. Partnering with the global design company IDEO, D4V provides both hands-on assistance and coaching to help startups create value via human-centered customer experiences and interactions.
Show more...Investment focus
- Industry: Software, Financial Services, E-Commerce
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Japan, United States, Singapore
Investor stats
- Total investments: 86
- Round size: Seed $443k–$7M; Series A $1.2M–$10M; Venture - Series Unknown $292k–$14M
- Lead/follow: 14% lead, 86% follow
- Last fund: May invest from a new fund soon — raised $46M in 2018
Portfolio highlights
- Sazo — Sazo specializes in constructing a global e-commerce and logistics network with AI.
- Dioseve — Dioseve is providing novel possibilities for all life.
- Genba Hub — Genba Hub specializes in providing business management systems for construction and maintenance enterprises.
Medical Investor funding in Japan at a glance
Stats across 878 deals from 971 investors.
Access all 971 investors in Japan Medical startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Investors in Japan investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 971 investors investing in Japan Medical startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!